• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Reckitt Benckiser Group (LSE:RKT), What Is Behind The Fresh Attention?

    Simply Wall St·10/13/2026 03:34:42
    語音播報

    Reckitt Benckiser Group (LSE:RKT) has reshaped its South Asia health leadership by appointing former Hindustan Unilever executive Guntas Randhawa as Regional Marketing Director. The move places Dettol, Durex, Strepsils and Gaviscon under her remit.

    Reckitt Benckiser Group’s share price has climbed 6.69% over the past week and 4.89% across 90 days, hinting at improving momentum despite a year-to-date share price return that is down 16.29% and a 1-year total shareholder return that has slipped 5.14%.

    Compare Reckitt Benckiser Group’s recent momentum with a curated set of resilient consumer-focused stocks in the 4 resilient stocks with low risk scores, which may be handling current conditions with steadier risk profiles.

    After a sharp weekly rebound but a weaker year-to-date record, Reckitt Benckiser Group now poses a simple question for new money: Does the current valuation still offer enough upside to justify the risk from here?

    Most Popular Narrative: 16% Undervalued

    Reckitt Benckiser Group closed at £52.16, compared with a widely followed fair value narrative of about £61.82 per share. The current price therefore sits at a clear discount that depends on whether the long term thesis plays out as outlined.

    The Fuel for Growth program is delivering fixed cost reductions and operational simplification ahead of plan, enabling greater reinvestment into brand marketing and innovation, which will likely create a virtuous cycle for further market share gains and improved earnings quality.

    See why 69 investors see Reckitt Benckiser Group as 16% undervalued.

    Result: Fair Value of £61.82 (UNDERVALUED)

    Still, legal disputes around product safety and US infant formula, plus pressure in slower European and North American categories, could easily upset the Reckitt Benckiser Group story.

    Find out about the key risks to this Reckitt Benckiser Group narrative.

    Next Steps

    Mixed messages in the Reckitt Benckiser Group story call for your own judgment, so move quickly through the data, weigh both the upside and the red flags, then review the 5 key rewards and 3 important warning signs.

    Looking for more Reckitt Benckiser Group sized opportunities?

    If you want to round out your view beyond Reckitt Benckiser Group, use the Simply Wall Street Screener to surface fresh ideas that match your risk and return preferences.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.